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Abstract 
Background: Ex vivo perfusion is used in our unit for kidneys donated after cardiac death (DCD). 
Perfusion flow index (PFI), resistance (RT) and perfusate Glutathione S Transferase (GST) can be 
measured to assess graft viability. We assessed whether measurements taken during perfusion could 
predict long-term outcome after transplantation. 
Methods: All DCD kidney transplants performed between 2002 and 2014 were included in this study. 
The exclusion criteria were unavailable data, kidneys not machine perfused, kidneys perfused on 
continuous mode and dual transplantation. There were 155 kidney transplants included in the final 
analysis. Demographic data, ischemia times, donor hypertension, graft function, survival and machine 
perfusion parameters after 3 hours were analysed. Each perfusion parameter was divided into three 
groups as high, medium, and low. Estimated glomerular filtration rate (eGFR) was calculated at 12 
months and then yearly after transplantation. 
Results: There was a significant association between graft survival and PFI, GST (p=0.020 and 
0.022, respectively). PFI was the only independent parameter to predict graft survival  
Conclusions: A low PFI during ex vivo hypothermic perfusion is associated with inferior graft survival 
after DCD kidney transplantation. We propose that PFI is a measure of the health of the graft 
vasculature and that a low PFI indicates vascular disease and therefore predicts a worse long-term 
outcome. 
Keywords: Ex vivo machine perfusion, graft survival, donation after cardiac death (DCD), perfusion 
flow index (PFI), pulsatile machine perfusion      
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Introduction 
The number of patients with end stage renal disease (is increasing [1] leading to a greater demand for 
renal replacement therapies. Transplantation is the most effective treatment for end stage renal 
disease providing a significant survival advantage over dialysis [2], however, the demand for kidney 
transplantation outstrips the supply of organs. Decreased numbers of donation after brain death 
(DBD) kidneys has led to increased interest in donation after cardiac death (DCD) kidney 
transplantation [3]. In 2007, only 9 countries performed DCD transplantation, performing 778 
transplants, but by 2014 this number had increased to 11 countries transplanting 3401 DCD kidneys 
[4, 5]. In 2007, 907 DBD and 300 DCD kidney transplants were performed in the UK. In 2013, whilst 
there was only a moderate increase in UK DBD transplants to 1160, the number of DCD transplants 
had more than doubled to 794 [1, 6, 7]. 
The main concern about DCD kidney transplantation is the magnitude of the ischaemic injury. It is 
greater than with DBD transplants because of the primary warm ischaemia time (WIT) between 
cardiac arrest and perfusion of the organs. The Maastricht Category was introduced to describe the 
clinical characteristics of DCD donors [8, 9]. Uncontrolled cardiac death (Maastricht Category I) 
describes donors who are declared dead outside of hospital. Maastricht Category II refers to donors 
unresponsive to resuscitation who are declared dead within hospital. Controlled cardiac death 
includes two subgroups: Maastricht Category III for donors awaiting cardiac arrest and Maastricht 
Category IV for donors suffering cardiac death after diagnosis of brain death. WIT is generally longer 
in uncontrolled categories. Gok et al found the longest WIT in Maastricht Category II donors with 
decreasing WIT in Maastricht Category III and IV. Delayed graft function was seen for 83.8 % of 
Maastricht Category II, 67.4 % of Maastricht Category III and 0% of Maastricht Category IV. However, 
one year graft survival was similar among these groups [10].  
In an attempt to reduce the damage caused by ischaemia, machine perfusion has been used in 
Newcastle since 1998 [11].  
One advantage of machine perfusion is its potential to assess the viability of a kidney, identifying 
organs at risk of primary non-function. Three parameters are measured by the Lifeport® perfusion 
machine: flow, pressure and resistance. Ischaemic injury causes loss of vasodilatation and potentially 
vessel occlusion due to thrombosis. Flow will be reduced as ischaemic injury increases so lower flow 
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rates could predict poorer graft function. Higher flow rates could be obtained by increasing perfusion 
pressure, however, may damage the kidney. To correct for pressure dependent variation in flow rate, 
we have used perfusion flow index (PFI) in our unit. Resistance (RT) is the second parameter that can 
be used to assess viability [8, 17]. It is an intrinsic property of the kidney that could be a biomarker of 
future function [18]. Resistance alsoreflects loss of vasodilatation caused by ischaemic injury. 
Glutathione S Transferases (GST) are a family of enzymes involved in toxin metabolism and found in 
different tissues [19]. GST levels may predict magnitude of cell membrane damage and cell death 
caused by ischaemic injury and has been shown to be a marker of kidney injury during machine 
perfusion [20].  
Machine perfusion characteristics and perfusate total GST were routinely used in our unit to assess 
whether kidneys are suitable for transplant [21]. This was found to be more important for Maastricht 
Category II kidneys as for controlled donors very few are considered too poor to transplant [10]. The 
aim of this study is to determine whether machine perfusion characteristics measured prior to 
transplant are predictive of long-term outcome.    
 
Materials and Methods 
Patient cohort 
All DCD kidney transplants between 2002 and 2014 were assessed for inclusion in the study. Dual 
transplants, kidneys not machine perfused, patients with incomplete data sets (<2/3 measurements 
available) and kidneys perfused in continuous mode were excluded from the study. Figure 1 
summarises patient numbers and the reason for the exclusion from the final analysis. Details 
regarding donors’ sex, age, and blood pressure history were collected from donor request forms. 
Maastricht Category, first and second WIT, cold ischaemic time and total ischaemic time were 
obtained from the clinical notes.   
Details about recipients were collected from the hospital’s medical record system. The recipients’ age, 
sex, graft and patient survival times, creatinine values at 12 months and yearly until 5 years after 
transplantation and estimated glomerular filtration rates (eGFR) were calculated using the 4 point 
MDRD equation.  
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Perfusion data 
Machine perfusion data including machine type, PFI, RT and GST concentrations were collected. 
Once the kidney was connected to the Lifeport, systolic pressure was increased to a maximum of 30 
mmHg and fixed at that pressure. PFI is calculated by dividing flow by systolic pressure and 
expressed as ml/min/mmHg per 100 g of kidney [16]. RT is calculated as mean pressure divided by 
flow at specified time and presented as mmHg/ml/min. Total GST level were measured from the 
perfusate fluid [21]. Perfusion measurements and 10 mls of perfusate for GST analysis were taken at 
the third hour of perfusion.  
All parameters were categorized into 3 groups empirically; low, medium and high. PFI values were: 
ORZPHGLXPWRDQGKLJKPOPLQPP+J per 100 g of kidney. RT groups were: 
ORZPHGLXPWRDQGKLJKPP+JPOPLQ*67JURXSVZHUHORZPHGLXP
WRDQGKLJK,8/Ser 100g of kidney.  
Statistical analysis 
Scientific Package for Social Science (version 15.0; SPSS Inc., Chicago, IL, USA) was used for 
statistical analyses. Chi-square test, independent-samples t test and Kruskall-Wallis tests were used 
for comparison of variables. Bonferonni correction was applied for pairwise comparisons. Kaplan–
Meier curves and log rank method were used for graft survival. Cox regression models were used to 
evaluate independent parameters of graft survival. A linear regression was performed to find 
independent predictors of eGFR.  
Results 
All patients undergoing DCD kidney transplantation between 2002 and 2014 at the Freeman Hospital, 
Newcastle upon Tyne were reviewed (n=403). After exclusion criteria were applied 155 kidney 
transplant recipients were included in the final analysis (Figure 1). 
Demographic characteristics of all patients included in the analysis are presented in Table 1. The 
median age of recipients was 55 years and of donors was 50 years. Males were predominant, both as 
donors and recipients. Kidneys were Maastricht Category III in 92.9 % of transplants. Hypertension 
was present in 18.1% of donors.  
The effect of donor hypertension on perfusion parameters and transplant outcome 
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Mean age of hypertensive donors was significantly higher than non-hypertensive donors (p<0.001). 
The distribution of PFI status was significantly different in hypertensive donor group compared to the 
non-hypertensive donor group (p=0.03), with a higher proportion of kidneys with low PFI from 
hypertensive donors, presumably due to changes in renal vasculature. There was no significant 
relationship between RT or GST grouping and donor hypertension (p=0.051 and 0.342, respectively) 
(Table 2).  eGFR was significantly higher in recipients of a kidney from a non-hypertensive donor 12 
months after transplant (p=0.049). No differences were seen in eGFR beyond 12 months. There was 
no relationship between donor hypertension and graft survival (p=0.781) (Figure 2).  
The relationship between perfusion parameters, donor and graft characteristics 
PFI, RT, and GST measurements of DCD kidneys after 3 hours of perfusion (n=131, 130 and 87 
respectively) were grouped into three categories as detailed in the methods section. Demographic 
and other parameters for the PFI groups are presented in Table 3. A Kruskal-Wallis test showed that 
there was a significant difference in PFI related to age (p=0.001) Donor age was 55.5 years in low PFI 
group,  () 46.5 years in high PFI group and 47 years in medium PFI group () indicating lower flow rate 
for a given perfusion pressure in kidneys from older donors (Supplementary Figure 1). Pairwise 
comparisons showed significant differences in age between low versus medium and low versus high 
PFI groups. 1st WIT was similar among PFI groups.   
Demographic and graft characteristics in the GST groups are given in Table 4. Data were not 
available for all patients (n=87). All kidneys in the low GST group were Maastricht Category III type. In 
contrast, in the high GST group 17.2% of donors were Maastricht Category II (p=0.02, Chi-square 
test). The first WIT was longer in the high GST group (18.3±5.9, 18.7±5.8, 22±5.3, low, medium, high 
GST groups respectively, p=0.016). Maastricht type and the duration of first WIT are therefore the 
major parameters influencing perfusate GST concentration.Most of the donors from the high RT group 
were female (64.7%) compared to 29.7% and 32.1% in the low and medium groups respectively 
(p=0.002). There was no significant difference in frequency of donor hypertension among the GST or 
RT groups (Tables 4 and 5). 
Relationship between perfusion parameters and long- term graft survival and function 
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PFI was significantly associated with outcome (p=0.02 by log rank analysis). Patients receiving a 
kidney with a high PFI had  superior transplant survival (Figure 3A). Pairwise comparison 
demonstrated a statistically significant survival difference in survival between low and high PFI groups 
(p=0.005) and medium and high PFI groups (p=0.048). Cox regression analysis demonstrated that 
PFI was an independent predictor of graft survival (p=0.021) in a model including donor age, recipient 
age,RT group, cold ischaemia time (Table 6). The hazard ratio for graft loss was 4.752 (CI: 1.283-
17.594 p=0.02) in the medium PFI and 10.733(CI 1.919-60.021 p=0.007) in the low PFI group 
compared to high PFI group. Graft survival was significantly different among GST groups (Figure 3B). 
Patients in the medium GST group had the worst graft survival (p=0.022). Graft survival did not differ 
between RT groups (p=0.472) (Figure 3C). 
There was a significant association between eGFR measured at 12, 24, 36, 48 months post 
transplant and PFI grouping (p<0.05 for all) (Figure 4A). Comparison of mean eGFR between low 
versus medium PFI groups and low versus high PFI groups were also significant at all time points 
(p<0.05 for all analyses). Pairwise comparisons of eGFR between medium and high PFI groups were 
similar (p>0.05 for all analyses). A low PFI is therefore a predictor of a lower eGFR up to 4 years post-
transplant. There was no significant association between GST or RT and eGFR at 12, 24, 36, 48 
months post-transplant (p>0.05 for all analyses) (Figure 4B and C). However, using multiple linear 
regression analysis with the variables donor age and sex, recipient age and sex, donor hypertension 
and PFI, GST, RT grouping, PFI was not independently associated with eGFR. The main independent 
effect on eGFR was donor age (12 months: p=0.003, B=-0.486; 24 months: p=0.005, B=-0.553; 36 
months: p=0.021, B=-0.492) (see the Supplementary Table 1).    
 
Discussion  
Measurements taken during machine perfusion have been used in our centre to define the viability of 
kidneys from DCD donors. This has been most useful in Maastricht Category II donor kidneys as the 
viability of kidneys from Maastricht Category III and IV donors is usually good [3, 11]. In this study, we  
used machine perfusion data primarily from Maastricht Category III DCD kidneys that have been 
transplanted to  assess the relationship between these measurements and longer term graft survival 
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and function. We found that PFI can predict graft survival whereas donor age is a more important for 
predictor of eGFR. To the best of our knowledge, this is the first evaluation of the relationship 
between PFI and graft survival.  
Evidence of the benefits of machine perfusion is conflicting. Moers et al have shown better 1 year 
graft survival and lower delayed graft function rates after machine perfusion MP in a cohort 
composing both DCD (n=42) and DBD kidneys (n=294) [12] and these findings were replicated in 
other studies [13, 14]. However, Moers have stated later on that three years after transplantation 
machine perfusion MP had no advantage over cold storage in terms of graft survival in DCD kidney 
transplantation. In addition, a multicentre study conducted in the UK showed no advantage of 
machine perfusion MP over cold storage in terms of incidence of delayed graft function, renal function 
and 1 year graft and patient survival [15]. A meta-analysis also showed that machine perfusion 
decreased the incidence of delayed graft function compared to static cold storage but graft and 
patient survival at 1 year were similar  [23]. The main focus of our study, however, was exploring the 
relationship between machine perfusion parameters and graft survival rather than comparison of 
machine perfusion with cold storage.  
A minority of donors were hypertensive. There was no relationship between donor hypertension and 
graft survival. This contrasts with earlier work that found donor hypertension may have an effect on 
graft survival [24-26]. The number of patients in our study with hypertension may have been 
insufficient to demonstrate this effect and diagnosis or reporting of donor hypertension may have 
been incomplete; this result should therefore be explored in further research with a larger group of 
patients. As would be expected hypertensive donors were older than non hypertensive donors. Donor 
hypertension was more frequent in the low PFI and high RT group. The reason for this might be 
increased stiffness of vessels relating to high blood pressure and possible comorbid conditions 
including atherosclerosis. As stiffness increases, loss of vascular compliance will result in increased 
resistance to flow and lower PFI.  
PFI groups were different in terms of graft survival time with recipients of a kidney from the high PFI 
group having better graft survival compared to the other groups. Pairwise comparisons showed that 
survival of kidneys in the high PFI group was superior to those from the low and medium PFI groups. 
PFI level was concordant with eGFR values at 12, 24, 36, 48 months post transplantation with lower 
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eGFRs in recipients of kidneys from the low PFI group compared to medium and high PFI groups. 
There was a negative correlation between PFI and donor age, with PFI increasing with decreasing 
donor age, perhaps reflecting age related changes in the renal vascular bed (Supplementary Figure 
1). This suggests that the changes in renal vasculature associated with low perfusate flow are also 
associated with and predictive of worse long-term graft survival. 
Donor age has been found as a factor affecting graft survival in DCD kidney transplantation in other 
studies. Although there was a relationship between donor ages in univariate analysis, PFI was the 
only independent predictor of graft survival in multivariate analysis. 
There was no association between graft survival, eGFR and RT. Similar to our study, Vries et al also 
found that renovascular resistance during machine perfusion did not relate to graft and patient 
survival [27]. In contrast, Jochmans et al has found that RT was an independent risk factor for 
delayed graft function and 1-year graft failure [28]. Patients in the medium GST group had worse graft 
survival and similar eGFR values compared to low and high groups. ). The reason for this is unclear 
and cannot be explained by injury to the graft prior to recovery of organs. This relationship was no 
longer significant when multivariate analysis was performed and the absence of a relationship with 
eGFR suggests that this is observation is not biologically significant. Moers et al has looked for a 
relationship between perfusate parameters (lactate dehydrogenase, aspartate aminotransferase, total 
glutathione-S-transferase, alanine-aminopeptidase, N-acetyl-D-glucosaminidase, and heart type fatty 
acid binding protein) and graft survival. None were predictive of graft survival [20]. Gok et al found 
similar results for GST levels and graft survival [29]. PFI therefore appears unique in its ability to 
predict survival, however this needs to be validated in a second cohort. 
There were some limitations of our study. Although we data from 155 patients into the analysis, this 
was after having excluded almost half of our initial population due to missing data. It is possible, 
though we believe unlikely, that there were systematic differences between those patients who were 
excluded from the analysis due to missing data, and those who were included. As data were not 
available for all patients some of the confidence intervals were wide, increasing the risk of a type 2 
error. We also did not have data regarding delayed graft function which was related with machine 
perfusion parameters in some studies [15]. 
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In summary, PFI is a unique and independent parameter to predict graft survival in DCD kidney 
transplantation. Donor age is still important for prediction of eGFR.  
Legends to Figures 
 
Figure 1. Details of patient cohort. 
All DCD kidney transplantations from 2002-2014 were included into the study. 
Figure 2. Donor hypertension and graft survival.   
Solid line represents donors with hypertension. Dashed line represents donors without hypertension. 
Graft survival was not statistically different (p=0.781). 
Figure 3. Relationship between machine perfusion parameters and graft survival.  
Solid line represent high, dotted line represent medium, dashed line represent low group of machine 
parameter in each figure. Kaplan Meier curves of A. PFI groups (P=0.020), B. GST groups (P=0.022), 
C. RT groups (P=0.472). 
Figure 4. Relationship between machine perfusion parameters and eGFR.  
Comparison of eGFR among PFI (A), RT (B) and GST (C) groups at 12, 24, 36, 48 months post 
transplantation. Solid columns represent low, dotted columns represent medium, striped columns 
represent high group for each parameter. The number of patients in each group is given at the bottom 
of each figure. Estimated glomerular filtration rate (eGFR) is given as meanrstandard deviation (SD). 
*P<0.05, **P<0.01. 
 
Abbreviations: 
DBD: Donation after brain death  
DCD: Donation after cardiac death  
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eGFR: Estimated glomerular filtration rate 
GST: Glutathione S Transferase 
PFI: Perfusion flow index  
RT: Resistance  
WIT: Warm ischaemia time  
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